Using ihMT MRI to assess myelin disruption in multiple sclerosis
Official title: Application of the Inhomogeneous Magnetisation Transfer MRI (ihMT) Technique, a New Myelin-specific MRI Technique, in Multiple Sclerosis
Run by Assistance Publique Hopitaux De Marseille · NCT03600779 · Data updated 2026-11-12
This study is trying out a new MRI technique to see if it can help track changes in myelin for people with early relapsing-remitting multiple sclerosis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | All |
| Enrollment | 85 (estimated) |
| Sponsor | Assistance Publique Hopitaux De Marseille Academic / other |
| Locations | 1 site (Marseille, PACA) |
| Status | Recruiting |
| Started | June 14, 2018 |
| Main results expected | August 14, 2027 |
| Study ends | August 14, 2028 |
| Registry record updated | August 6, 2026 |
| Trial ID | NCT03600779 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 to 45 with relapsing-remitting multiple sclerosis and active lesions on MRI.
✕Probably not a fit
Patients with progressive forms of MS or those with contraindications for MRI will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project aims to develop in vivo biomarkers that can effectively monitor demyelination and remyelination processes in patients with multiple sclerosis (MS). The study utilizes a novel imaging technique called inhomogeneous Magnetisation Transfer (ihMT), which has shown promise in preliminary studies for its sensitivity in evaluating myelin disruption. By focusing on patients with early relapsing-remitting MS, the study seeks to measure and describe the spontaneous demyelination and remyelination processes involved in active lesions. Participants will undergo MRI scans to assess these processes over time.
Why it matters
Potential benefit: If successful, this study could provide a new method for monitoring the effectiveness of therapies aimed at repairing myelin in MS patients.
How similar studies have gone: Preliminary studies using similar ihMT techniques have shown promising results, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * For Patients and Controls : * Adult patient, male and female, age 18 to 45 * Patient affiliated with health insurance coverage, * Patient who signed a free and informed consent after receiving detailed, understandable and honest information, * For patients only : * Patient with relapsing-remitting multiple sclerosis according to the McDonald 2010 criteria or progressive * Patients treated or not treated with first-line disease modifying therapy * Detection of at least one post-Gadolinium injection active lesion identified on the initial brain MRI (T0) or a chronic active lesion (PRL: Paramagnetic rim lesions) Exclusion Criteria: * For patients only : • Patients with a progressive form of MS other than the early relapsing-remitting form (primary progressive or secondary progressive) * For Patients and Controls : * Patients with the usual contraindications for MRI (pacemaker, agitation, metal shards, claustrophobia) * Patients at risk of non-compliance to the exam: basic problems with understanding, confusion, involuntary movements, poor tolerance of prolonged supine position * Patients who are unable to give their consent: problems with understanding, lack of vigilance, confusion * Woman who is pregnant and breastfeeding * Patients with a history of neurological or psychiatric condition * Patients under guardianship or trusteeship
Where it's running
-
Assistance Publique Des Hotipaux de Marseille
Marseille, Paca, France Recruiting
Study contacts
- Study coordinator: Jean Pelletier, Md
- Email: Jean.PELLETIER@ap-hm.fr
- Phone: +33 491388204
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Digital therapeutic program combining dance and music for chronic neurological disorders
This study is testing a new dance and music program to see if it can help people with Multiple Sclerosis and early signs of cognitive decline feel better and improve their daily life.
-
Monitoring pregnancies in women with multiple sclerosis
This study is trying to see how pregnancy affects women with multiple sclerosis and their babies, while also looking at treatments and breastfeeding.
-
Cryopreserved autologous SVF plus micrograft for refractory ano-perineal fistulas in Crohn's disease
This trial tests whether thawed stromal vascular fraction (SVF) injected around fistulas can help Crohn’s patients who haven’t responded to prior therapy.
-
Prevention of Recidivism and Better Care for Women Seeking Asylum Who Endure Sexual Violence
This study tests a coordinated care model to support adult women seeking asylum in France who have experienced sexual violence, with the aim of improving health and quality of life.
-
Transition to adulthood for young adults with severe haemophilia
This study tests how young adults with severe haemophilia who were in TRANSHEMO as teens are faring as they move into adulthood.
-
Biomarkers of Response to SEEG Thermocoagulation
This study tests biomarkers to see if they predict how well SEEG-guided radiofrequency thermocoagulation helps people with drug-resistant focal epilepsy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.